Fly News Breaks for February 13, 2020
Feb 13, 2020 | 09:38 EDT
JPMorgan analyst Christopher Horvers lowered his price target for Bed Bath & Beyond to $10 from $13 and keeps a Neutral rating on the shares. The company's Q4 sales announcement is evidence that "things are likely to get worse before they get better," Horvers tells investors in a research note. It does not pay to be early to turnarounds, especially in a moderating environment, adds the analyst. Horvers thinks the stock would be in the high-single digit range if it weren't for the potential asset sales ahead, which he believes risks a "sell-the-news event" given the catalyst driven nature of some Bed Bath investors.
News For BBBY From the Last 2 Days
Oct 18, 2021 | 13:45 EDT
Bullish option flow detected in Bed Bath & Beyond with 39,133 calls trading, 1.7x expected, and implied vol increasing over 1 point to 59.06%. 10/22 weekly 15 calls and 10/22 weekly 16 calls are the most active options, with total volume in those strikes near 14,500 contracts. The Put/Call Ratio is 0.26. Earnings are expected on January 5th.